Brazil · Delayed Price · Currency is BRL Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of BRL 157.81 billion. The enterprise value is 164.48 billion.
| Market Cap | 157.81B |
| Enterprise Value | 164.48B |
Important Dates
The next estimated earnings date is Friday, May 1, 2026.
| Earnings Date | May 1, 2026 |
| Ex-Dividend Date | Feb 23, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 94.52% |
| Float | 242.43M |
Valuation Ratios
The trailing PE ratio is 29.94 and the forward PE ratio is 22.30.
| PE Ratio | 29.94 |
| Forward PE | 22.30 |
| PS Ratio | 3.17 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 32.71 |
| P/FCF Ratio | 32.82 |
| P/OCF Ratio | 23.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.30, with an EV/FCF ratio of 34.21.
| EV / Earnings | 31.20 |
| EV / Sales | 3.45 |
| EV / EBITDA | 15.30 |
| EV / EBIT | 23.62 |
| EV / FCF | 34.21 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.63 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.21 |
| Debt / FCF | 2.84 |
| Interest Coverage | 45.48 |
Financial Efficiency
Return on equity (ROE) is 8.40% and return on invested capital (ROIC) is 8.46%.
| Return on Equity (ROE) | 8.40% |
| Return on Assets (ROA) | 4.83% |
| Return on Invested Capital (ROIC) | 8.46% |
| Return on Capital Employed (ROCE) | 8.93% |
| Weighted Average Cost of Capital (WACC) | 9.91% |
| Revenue Per Employee | 2.26M |
| Profits Per Employee | 239,598 |
| Employee Count | 22,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 5.62 |
Taxes
In the past 12 months, Xylem has paid 1.27 billion in taxes.
| Income Tax | 1.27B |
| Effective Tax Rate | 19.56% |
Stock Price Statistics
The stock price has decreased by -11.57% in the last 52 weeks. The beta is 1.17, so Xylem's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -11.57% |
| 50-Day Moving Average | 323.62 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 46.60 |
| Average Volume (20 Days) | 344 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.77 |
Income Statement
In the last 12 months, Xylem had revenue of BRL 49.76 billion and earned 5.27 billion in profits. Earnings per share was 21.59.
| Revenue | 49.76B |
| Gross Profit | 19.14B |
| Operating Income | 7.27B |
| Pretax Income | 6.50B |
| Net Income | 5.27B |
| EBITDA | 10.43B |
| EBIT | 7.27B |
| Earnings Per Share (EPS) | 21.59 |
Balance Sheet
The company has 8.15 billion in cash and 13.63 billion in debt, with a net cash position of -5.49 billion.
| Cash & Cash Equivalents | 8.15B |
| Total Debt | 13.63B |
| Net Cash | -5.49B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 64.71B |
| Book Value Per Share | 259.59 |
| Working Capital | 9.83B |
Cash Flow
In the last 12 months, operating cash flow was 6.84 billion and capital expenditures -2.03 billion, giving a free cash flow of 4.81 billion.
| Operating Cash Flow | 6.84B |
| Capital Expenditures | -2.03B |
| Free Cash Flow | 4.81B |
| FCF Per Share | n/a |
Margins
Gross margin is 38.46%, with operating and profit margins of 14.60% and 10.59%.
| Gross Margin | 38.46% |
| Operating Margin | 14.60% |
| Pretax Margin | 13.07% |
| Profit Margin | 10.59% |
| EBITDA Margin | 20.96% |
| EBIT Margin | 14.60% |
| FCF Margin | 9.66% |
Dividends & Yields
This stock pays an annual dividend of 2.97, which amounts to a dividend yield of 0.89%.
| Dividend Per Share | 2.97 |
| Dividend Yield | 0.89% |
| Dividend Growth (YoY) | 3.98% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 40.86% |
| Buyback Yield | -0.19% |
| Shareholder Yield | 0.69% |
| Earnings Yield | 3.34% |
| FCF Yield | 3.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.45 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.45 |
| Piotroski F-Score | 7 |